The fastest way to find a clinical trial is through ClinicalTrials.gov, a free database run by the U.S. government that lists over 400,000 studies worldwide. But it’s not the only option, and knowing how to search effectively can make the difference between finding a relevant trial and getting buried in results. Here’s how to navigate the process from search to enrollment.
Start With ClinicalTrials.gov
ClinicalTrials.gov is the largest and most comprehensive trial database in the world. You can search by condition, treatment, or keyword from the homepage. The real power is in the filters. A “Focus Your Search” menu lets you narrow results by location, age group, sex, and, most importantly, study status.
The status filter is critical. If you’re looking to join a trial now, filter for “Recruiting” studies, which are actively looking for participants. You may also see “Not yet recruiting” (the study exists but hasn’t started enrollment) or “Enrolling by invitation” (the research team is selecting from a specific population and isn’t accepting general applicants). Ignore studies marked “Completed,” “Terminated,” or “Withdrawn” unless you’re researching past results.
Each listing includes a description of the study, eligibility requirements, locations, and contact information for the research team. You can reach out directly to the study coordinator listed on the page.
Disease-Specific Registries
For certain conditions, specialized registries can connect you with trials that may not be easy to find through a general search. Cancer patients have several options: the National Cancer Institute runs its own trial finder, and organizations like the Multiple Myeloma Research Foundation and Susan G. Komen maintain research registries for specific cancer types.
Rare diseases have an especially deep network of registries. The NIH maintains a long list that includes condition-specific databases for cystic fibrosis, ALS, lupus, muscular dystrophy, sarcoidosis, and dozens of genetic conditions. Organizations like Global Genes RARE-X and Simons Searchlight focus on connecting patients with rare genetic and neurodevelopmental disorders to active research. If you have a rare condition, your best starting point may be the patient advocacy organization for that disease, as many run their own registries specifically designed to match patients with trials.
Understanding Trial Phases
Clinical trials run in four phases, and the phase tells you a lot about what to expect as a participant.
- Phase I involves 20 to 80 people. The goal is to test safety and identify side effects of a new drug or treatment for the first time in humans. These trials carry the most uncertainty.
- Phase II expands to 100 to 300 people and focuses on whether the treatment actually works, while continuing to monitor safety.
- Phase III enrolls 1,000 to 3,000 people and compares the new treatment against standard care. This is the phase that generates the evidence needed for FDA approval.
- Phase IV happens after a drug is already approved and available. Researchers track its safety and effectiveness in the general population over time.
Earlier phases tend to involve more frequent visits and closer monitoring. Later phases feel more like routine medical care but with additional tests and check-ins. Knowing the phase helps you gauge both the potential benefit and the time commitment involved.
How Eligibility Criteria Work
Every trial has inclusion criteria (what you need to qualify) and exclusion criteria (what disqualifies you). These exist to ensure the results are meaningful and that participants are safe.
Common inclusion criteria include having a specific stage of disease, carrying a particular genetic mutation, or falling within a certain age range. Exclusion criteria often involve other health conditions that could complicate results, medications you’re currently taking, or pregnancy. One NIH analysis found that about 27% of trials for diseases common in older adults excluded participants based on age, sometimes with arbitrary upper limits. If you’re older, it’s worth looking specifically for trials without restrictive age cutoffs.
Don’t assume you’re ineligible just because one criterion seems like it might apply. Eligibility is determined through a screening process after you contact the study team. If you’re close to meeting the criteria, reach out anyway.
What Happens Before You Enroll
Before you formally join any trial, you’ll go through an informed consent process. This isn’t just signing a form. The research team is legally required to explain the purpose of the study, how long your participation will last, what procedures are involved, and which of those procedures are experimental.
You must also be told about foreseeable risks or discomforts, potential benefits to you or others, alternative treatments you could pursue instead, and how your personal information will be protected. For studies involving more than minimal risk, the team has to explain whether compensation or medical treatment is available if you’re injured during the trial. You’ll receive contact information for someone who can answer questions about your rights as a participant.
The most important thing to understand: participation is voluntary. You can refuse to join without any penalty, and you can withdraw at any time without losing access to benefits or care you’re otherwise entitled to. No one can pressure you into staying.
Questions Worth Asking
Before committing, ask the research team specific questions. The National Library of Medicine recommends asking why researchers believe the treatment being tested might work, and why it might not. Ask what interventions you might receive during the trial (some participants receive a placebo or the standard treatment rather than the experimental one). Ask how the risks and side effects compare with your current treatment, and who will oversee your medical care while you’re in the study. If something goes wrong, you want to know what your options are before you start.
Who Pays for What
Clinical trials split costs into two categories. Research costs, like the experimental drug itself, lab tests done purely for the study, and extra imaging or doctor visits beyond your normal care, are typically covered by the trial’s sponsor. You generally won’t pay for these.
Patient care costs are the expenses you’d have whether or not you were in a trial: regular doctor visits, hospital stays, standard treatments, and routine lab work. These are usually billed to your insurance the same way they would be otherwise. Medicare covers routine patient care costs in clinical trials. Medicaid does the same. TRICARE reimburses costs for NCI-sponsored cancer trials, and the Department of Veterans Affairs allows eligible veterans to participate in NCI-sponsored trials at VA Medical Centers.
If you’re concerned about travel, some trials offer help. NIH-run studies, for example, may reimburse hotel stays at $120 per night for participants who live more than 50 miles from the research site, and certain programs cover airfare. Younger patients sometimes qualify for free lodging at facilities like the Children’s Inn at NIH. These benefits vary widely by trial, so ask the study coordinator what support is available before you assume you can’t afford to participate.
Getting Help With the Search
If searching databases on your own feels overwhelming, patient navigation programs can help. Many cancer centers offer free navigators who provide education about clinical trials and help you understand your options. These programs don’t typically enroll you directly, but they can walk you through how trials work, explain what’s available for your condition, and help you take the next step. Some offer services in multiple languages.
Your own doctor is another resource. Oncologists and specialists often know about trials at their institution or through professional networks that may not surface easily in a database search. If a trial interests you, bring the listing to your next appointment and ask whether it could be a good fit alongside your current care plan.